Anticlastogenic effect of apigenin in human lymphocytes treated with ethinylestradiol

Fitoterapia

Volumn 81, Issue 6, 2010, Pages 590-594

  Siddique, Yasir Hasan ^a   Ara, Gulshan ^a   Beg, Tanveer ^a   Afzal, Mohammad ^a  

^a ALIGARH MUSLIM UNIVERSITY   (India)

Author keywords

Antigenotoxicity; Apigenin; Ethinylestradiol; Natural plant products

Indexed keywords

APIGENIN; ETHINYLESTRADIOL;

ANTICLASTOGENIC EFFECT; ARTICLE; CELL CYCLE; CELL PROTECTION; CHROMOSOME ABERRATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; DRUG STRUCTURE; GENOTOXICITY; HUMAN; HUMAN CELL; LYMPHOCYTE; PRIORITY JOURNAL; SISTER CHROMATID EXCHANGE;

ADULT; APIGENIN; CELL CYCLE; CHROMOSOME ABERRATIONS; DRUG EVALUATION, PRECLINICAL; ETHINYL ESTRADIOL; FEMALE; HUMANS; LYMPHOCYTES; MUTAGENS; SISTER CHROMATID EXCHANGE; YOUNG ADULT;

EID: 77955713089     PISSN: 0367326X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fitote.2010.02.003     Document Type: Article

References (58)

1. ROC, Fourth Report on Carcinogens, US DHHS, National Toxicology Program. (1985).
2. H.F.P. Joosten, F.A.A. van Acker, D.J. van den Dobbelsteen, G.J.M.J. Horbach, and E.I. Kranjc Toxicol Lett 151 2004 113 134
3. HSDB. Estrone. http://toxnet.nml.nim.gov/cgi-bin/sis/htmlgen? HSDB (& type estrone) Hazardous Substance Data Bank, National Library of Medicine, (2000).
4. T.H. Schwent, and J.S. Lippman E.J. Pavlik, Estrogens, Progestins and their antagonists 1996 Birkhauser Boston 273 296
5. D.C. Blakey, and I.N.H. White Carcinogenesis 6 1985 1201 1205
6. A. Martelli, F. Mattioli, M. Angiola, R. Reimann, and G. Brambilla Mutat Res 536 2003 69 78
7. M. Shimomura, S. Higashi, and K. Mizumoto Jpn J Cancer Res 83 1992 438 444
8. W.J. Wheeler, L.M. Cherry, T. Downs, and J.C. Hsu Mutat Res 171 1986 31 41
9. Y. Sato, Y. Sakakibara, T. Oda, E. Aizu-Yokota, and K. Ichimoseki Chem Pharm Bull 40 1992 182 184
10. Y.H. Siddique, T. Beg, and M. Afzal Chem Biol Interact 151 2005 133 141
11. B.S. Hundal, V.S. Dhillon, and I.S. Sidhu Mutat Res 389 1997 173 181
12. T.S. Kochhar Experientia 44 1985 62 63
13. H. Shimazu, N. Shiraishi, T. Akematsu, N. Ueda, and T. Sugiyana Mutat Res 38 1976 347
14. D. Loncar, O. Milosevic-Djordjevi, A. Zivanovic, D. Grujicic, and S. Arsenijevic Contraception 69 2004 327 331
15. R.S. Doppalapudi, E.S. Riccio, L.L. Rausch, J.A. Shimon, P.S. Lee, and K.E. Mortelmans Mutat Res 629 2007 148 160
16. G. Avani, and M.V. Rao Toxicol Invitro 626 2007 626 631
17. L. Hagmar, A. Brogger, I.L. Hansteen, S. Heims, B. Hoggstedt, and L. Knudsen Cancer Res 54 1994 2919 2922
18. L. Hagmar, I. Bonnasi, U. Stromberg, A. Brogger, J.E. Knudson, and H. Norppa Cancer Res 58 1998 4117 4121
19. S.H.H. Swierenga, J.A. Heddle, J.A. Sigal, J.P.W. Gilman, R.L. Brillinger, and G.R. Douglas Chinese Hamster lung and human lymphocyte cultures Mutat Res 246 1991 301 322
20. R.J. Albertini, D. Anderson, G.R. Douglas, L. Hagmar, K. Heminiki, and F. Merelo A Aitio Mutat Res 463 2000 111 172
21. Y.H. Siddique, and M. Afzal International J Pharmacol 4 2008 410 430
22. Y.H. Siddique, T. Beg, and M. Afzal Hum Exp Toxicol 24 2005 121 127
23. Y.H. Siddique, G. Ara, T. Beg, and M. Afzal Acta Biol Hung 58 2007 397 409
24. Y.H. Siddique, G. Ara, T. Beg, and M. Afzal Res J Biol 1 2006 69 73
25. Y.H. Siddique, G. Ara, T. Beg, M. Faisal, M. Ahmad, and M. Afzal Toxicol in vitro 22 2008 10 17
26. Y.H. Siddique, T. Beg, and M. Afzal Toxicol in vitro 20 2006 227 233
27. Y.H. Siddique, G. Ara, T. Beg, and M. Afzal J Env Biol 28 2007 279 282
28. Y.H. Siddique, and M. Afzal Indian J Exp Biol 43 2005 769 772
29. J. Peterson, and J. Dwyer Nutr Res 18 1995 1995 2018
30. D.L. Hoftman.(2000). < http://www.mpicentor.com/library/herbal/ materiamedica/chamomile.asp7.
31. PHS-149 (1974) US Department of Health and Human Services. 1974; p. 1042.
32. H.P. Kim, I. Mani, L. Iversen, and V.A. Zibou Leukot Essen Fatty acids 58 1998 17 24
33. Y.H. Siddique, T. Beg, and M. Afzal Toxicol in vitro 22 2008 625 631
34. M.A. Carballo, S. Alvarez, and A. Boveris Mutat Res 288 1993 215 222
35. D.M. Maron, and B.N. Ames Mutat Res 113 1983 173 215
36. IPCS WHO, Geneva vol. 46 1985 25 54
37. P. Perry, and S. Wolff Nature 251 1974 156 158
38. R.R. Tice, E.L. Schneider, and J.M. Rary Exp Cell Res 102 1976 232 236
39. P.E. Crossen, and W.F. Morgan Exp Cell Res 104 1977 453 457
40. J.L. Ivett, and R.R. Tice Environ Mutagen 4 1982 358
41. K.N. Rithidech, M. Tungjai, and E.B. Whorton Mutat Res 585 2005 96 106
42. R.D. Synder, and P.J. Gillies Environ Mol Mutagen 40 2002 266 276
43. Y. Shukla, and S.K. Pal Int J Hum Genet 4 2008 265 276
44. G.G. Duthie, S.J. Duthei, and J.A.M. Kyle Nutr Res Rev 13 2000 79 106
45. I. Maridonneau, P. Braquet, and R.P. Garay Pharm Res Commun 18 1986 61 72
46. M. Sannomiya, C.R.P. Cardoso, M.E. Figueiredo, C.M. Rodrigues, L.C. dos Santos, and F.V. dos Santos J Ethnopharmacol 112 2007 319 326
47. J.C. Lee, J. Kim, J.K. Park, G.H. Chung, and Y.S. Jang Exp Cell Res 291 2003 386 397
48. G. Galati, and J. O'Brien Free Rad Biol Med 37 2004 287 303
49. S.K. Katiyar, and H. Mukhtar Int J Oncol 8 1996 221 238
50. J. Fishman Ann Rev Physiol 45 1983 61 72
51. N.J. Maclusky, F. Maftolin, L.C. Krey, S. Franks. 15 (1981) 111-124.
52. J.D. Yager, and J.G. Liehr Ann Rev Pharmacol Toxicol 36 1996 203 232
53. J.L. Bolton, E. Pisha, F. Zhang, and S. Qiu Chem Res Toxicol 11 1998 1113 1127
54. X. Han, and J.G. Liehr Cancer Res 54 1994 5515 5517
55. S. Noel, M. Kasinathan, and S.K. Rath Toxicol in vitro 20 2006 1168 1172
56. C. Manach, A. Scalbert, C. Morand, C. Remesy, and L. Jimenez Am J Clin Nutr Res 79 2004 727 747
57. L.A.J. Heinemann, T. Dominh, I. Guggenmoos-Holzmann, C. Thie, E. Garbe, and A.R. Feinstein Contraception 56 1997 275 284
58. S. De Flora Mutat Res 402 1998 151 158